Allurion Technologies to implement reverse stock split
Seeking Alpha News (Tue, 24-Dec 7:21 AM ET)
Allurion Technologies, Inc. Announces Reverse Stock Split
Business Wire (Tue, 24-Dec 7:00 AM ET)
Allurion Announces NYSE Acceptance of Plan to Regain Listing Compliance
Business Wire (Mon, 2-Dec 8:00 AM ET)
Allurion Launches in the US with its First AI-Native Compounded GLP-1 Program
Business Wire (Mon, 25-Nov 8:00 AM ET)
Allurion Reports Third Quarter 2024 Financial Results and Provides Business Update
Business Wire (Wed, 13-Nov 8:00 AM ET)
Business Wire (Mon, 4-Nov 8:10 AM ET)
Allurion to Report Third Quarter 2024 Financial Results on November 13, 2024
Business Wire (Wed, 30-Oct 8:30 AM ET)
Business Wire (Wed, 23-Oct 8:00 AM ET)
Business Wire (Wed, 9-Oct 8:00 AM ET)
Coverage Initiation And Bullish Price Target Sends Micro Cap Flying
Yolowire (Wed, 2-Oct 10:59 AM ET)
Allurion Technologies Inc is a medical device company that focuses on creating a best-in-class weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
Allurion Technologies trades on the NYSE stock market under the symbol ALUR.
As of December 26, 2024, ALUR stock price climbed to $0.43 with 1,521,954 million shares trading.
ALUR has a beta of 2.12, meaning it tends to be more sensitive to market movements. ALUR has a correlation of 0.03 to the broad based SPY ETF.
ALUR has a market cap of $28.06 million. This is considered a Sub-Micro Cap stock.
Last quarter Allurion Technologies reported $5 million in Revenue and -$.14 earnings per share. This fell short of revenue expectation by $-3 million and exceeded earnings estimates by $.04.
The top ETF exchange traded funds that ALUR belongs to (by Net Assets): VTI, VXF, IWC.
ALUR has underperformed the market in the last year with a return of -87.8%, while the SPY ETF gained +28.5%. In the last 3 month period, ALUR fell short of the market, returning -33.4%, while SPY returned +5.6%. However, in the most recent 2 weeks ALUR has outperformed the stock market by returning +20.6%, while SPY returned +0.1%.
ALUR support price is $.35 and resistance is $.43 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALUR shares will trade within this expected range on the day.